Assessment of high-risk human papillomavirus infections using clinician- And self-collected cervical sampling methods in rural women from far Western Nepal

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Johnson, Derek C ^a   Bhatta, Madhav P ^b   Smith, Jennifer S ^c   Kempf, Mirjam Colette ^a   Broker, Thomas R ^d   Vermund, Sten H ^e   Chamot, Eric ^a   Aryal, Shilu ^f   Lhaki, Pema ^g   Shrestha, Sadeep ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b KENT STATE UNIVERSITY   (United States)

^c University of North Carolina at Chapel Hill   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^e VANDERBILT UNIVERSITY   (United States)

^f Family Health Division   (Nepal)

^g Nepal Fertility Care Center   (Nepal)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICIAN COLLECTED CERVICAL SAMPLING METHOD; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; CYTOLOGY; FEMALE; GYNECOLOGIC DISEASE; GYNECOLOGICAL EXAMINATION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 45; MAJOR CLINICAL STUDY; NEPAL; PAPILLOMAVIRUS INFECTION; PREVALENCE; RISK ASSESSMENT; RURAL POPULATION; SAMPLING; SELF COLLECTED CERVICAL SAMPLING METHOD; SQUAMOUS CELL CARCINOMA; SQUAMOUS INTRAEPITHELIAL LESION; ADOLESCENT; BEHAVIOR; DEMOGRAPHY; GENETICS; LABORATORY DIAGNOSIS; LABORATORY PERSONNEL; METABOLISM; MIDDLE AGED; PAPILLOMA VIRUS; PAPILLOMAVIRUS INFECTIONS; PHYSIOLOGY; PROCEDURES; SAMPLE SIZE; STATISTICS AND NUMERICAL DATA; VAGINA SMEAR; VIROLOGY; YOUNG ADULT;

MESSENGER RNA;

ADOLESCENT; ADULT; BEHAVIOR; DEMOGRAPHY; FEMALE; HUMANS; MEDICAL LABORATORY PERSONNEL; MIDDLE AGED; NEPAL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; RISK ASSESSMENT; RNA, MESSENGER; RURAL POPULATION; SAMPLE SIZE; SPECIMEN HANDLING; VAGINAL SMEARS; YOUNG ADULT;

EID: 84903648346     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0101255     Document Type: Article

References (39)

1. WHO/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre). Human Papillomavirus and Related Cancers in Nepal. Summary Report 2010. [Accessed: Nov 2013]. Available at www. who. int/ hpvcentre.
2. Franco EL, de Sanjose S, Broker TR, Stanley MA, Chevarie-Davis M, et al. (2012) Human papillomavirus and cancer prevention: gaps in knowledge and prospects for research, policy, and advocacy. Vaccine 30 Suppl 5: F175-182.
3. Wheeler CM (2013) The natural history of cervical human papillomavirus infections and cervical cancer: gaps in knowledge and future horizons. Obstet Gynecol Clin North Am 40: 165-176.
4. de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, et al. (2010) Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol 11: 1048-1056.
5. Smith JS, Melendy A, Rana RK, Pimenta JM (2008) Age-specific prevalence of infection with human papillomavirus in females: a global review. J Adolesc Health 43: S5-25, S25 e21-41.
6. Bhatla N, Lal N, Bao YP, Ng T, Qiao YL (2008) A meta-analysis of human papillomavirus type-distribution in women from South Asia: implications for vaccination. Vaccine 26: 2811-2817.
7. Sherpa AT, Clifford GM, Vaccarella S, Shrestha S, Nygard M, et al. (2010) Human papillomavirus infection in women with and without cervical cancer in Nepal. Cancer Causes Control 21: 323-330.
8. Bhusal CL, Manandhar S, Singh M, Shah A, Neupane S, et al. (2012) Evidence of HPV subtypes linked with cervical cancer in Nepal. WHO South-East Asia Journal of Public Health 1: 4.
9. Binu V, Chandrashekhar T, Subba S, Jacob S, Kakria A, et al. (2007) Cancer pattern in Western Nepal: a hospital based retrospective study. Asian Pac J Cancer Prev 8: 183-186.
10. Dhakal HP, Pradhan M (2009) Histological pattern of gynecological cancers. JNMA J Nepal Med Assoc 48: 301-305.
11. Pradhan B, Pradhan SB, Mital VP (2007) Correlation of PAP smear findings with clinical findings and cervical biopsy. Kathmandu Univ Med J (KUMJ) 5: 461-467.
12. Johnson D, Lhaki P, Chamot E, Steben M, Broker TR, et al. (2014) Prevalence and Correlates of Cervico-Vaginal Clinical Syndromes Among Women Attending a Health Camp in Lalitpur District of Nepal. Kathmandu Univ Med J (KUMJ) (in press).
13. Ministry of Health & Population, Government of Nepal (2013) http://www.mohp.gov.np/english/home/index.php.Accessed July 13th 2013. Kathmandu.
14. Central Bureau of Statistics (2012) Nepal Multiple Indicator Cluster Survey 2010, Mid-and Far-Western Regions, Final Report. Kathmandu: Central Bureau of Statistics and UNICEF Nepal.
15. Baral YR, Lyons K, Skinner J, van Teijlingen ER (2010) Determinants of skilled birth attendants for delivery in Nepal. Kathmandu Univ Med J (KUMJ) 8: 325-332.
16. Poudel KC, Jimba M, Okumura J, Joshi AB, Wakai S (2004) Migrants' risky sexual behaviours in India and at home in far western Nepal. Trop Med Int Health 9: 897-903.
17. Arbyn M, Verdoodt F, Snijders PJ, Verhoef VM, Suonio E, et al. (2014) Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis. Lancet Oncol 15: 172-183.
18. Zhao FH, Lewkowitz AK, Chen F, Lin MJ, Hu SY, et al. (2012) Pooled analysis of a self-sampling HPV DNA Test as a cervical cancer primary screening method. J Natl Cancer Inst 104: 178-188.
19. Lazcano-Ponce E, Lorincz AT, Cruz-Valdez A, Salmeron J, Uribe P, et al. (2011) Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial. Lancet 378: 1868-1873.
20. Gok M, Heideman DA, van Kemenade FJ, Berkhof J, Rozendaal L, et al. (2010) HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study. BMJ 340: c1040.
21. National Population and Housing Census 2011, National Planning Commission Secretariat, Central Bureau of Statistics, Kathmandu Nepal. Available at http://cbs.gov.np/wp-content/uploads/2012/11/National%20Report.pdf.
22. NFCC - Nepal Fertility Care Center (n.d.). Retrieved from http://nfcc.org.np/.
23. Ministry of Health and Population (MOHP) [Nepal], New ERA, and ICF International Inc. 2012. Nepal Demographic and Health Survey 2011. Kathmandu, Nepal: Ministry of Health and Population, New ERA, and ICF International, Calverton, Maryland.
24. Nepal Living Standards Survey 2010/2011, National Planning Commission Sectetariat, Central Bureau of Statistics. Available at http://cbs.gov.np/wp- content/ uploads/2012/02/Statistical-Report-Vol2.pdf.
25. Poertner E, Junginger M, Muller-Boker U (2011) Migration in far west Nepal: intergenerational linkages between internal and international migration of rural-to-urban migrants. Crit Asian Stud 43: 23-47.
26. Monsonego J, Hudgens MG, Zerat L, Zerat JC, Syrjanen K, et al. (2012) Risk assessment and clinical impact of liquid-based cytology, oncogenic human papillomavirus (HPV) DNA and mRNA testing in primary cervical cancer screening (the FASE study). Gynecol Oncol 125: 175-180.
27. Srivastava S, Gupta S, Roy JK (2012) High prevalence of oncogenic HPV-16 in cervical smears of asymptomatic women of eastern Uttar Pradesh, India: a population-based study. J Biosci 37: 63-72.
28. Bruni L, Diaz M, Castellsague X, Ferrer E, Bosch FX, et al. (2010) Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis 202: 1789-1799.
29. Clifford GM, Gallus S, Herrero R, Munoz N, Snijders PJ, et al. (2005) Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 366: 991-998.
30. Department of Health Services, Ministry of Health & Population (2010) National Guideline for Cervical Cancer Screening and Prevention in Nepal. Available at http://whonepal.healthrepository.org/bitstream/123456789/498/1/ National%20Guideline%20for%20CCSP.pdf.
31. Snijders PJ, Verhoef VM, Arbyn M, Ogilvie G, Minozzi S, et al. (2013) High-risk HPV testing on self-sampled versus clinician-collected specimens: a review on the clinical accuracy and impact on population attendance in cervical cancer screening. Int J Cancer 132: 2223-2236.
32. Rositch AF, Gatuguta A, Choi RY, Guthrie BL, Mackelprang RD, et al. (2012) Knowledge and acceptability of pap smears, self-sampling and HPV vaccination among adult women in Kenya. PLoS One 7: e40766.
33. International Agency for Research on Cancer (IARC) (2005) IARC Handbooks of Cancer Prevention: Cervix Cancer Screening, Chapter 2. Lyon, France: IARC Press.
34. Wright TC Jr, Denny L, Kuhn L, Pollack A, Lorincz A (2000) HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer. JAMA 283: 81-86.
35. Salmeron J, Lazcano-Ponce E, Lorincz A, Hernandez M, Hernandez P, et al. (2003) Comparison of HPV-based assays with Papanicolaou smears for cervical cancer screening in Morelos State, Mexico. Cancer Causes Control 14: 505-512.
36. Ting J, Mugo N, Kwatampora J, Hill C, Chitwa M, et al. (2013) High-risk human papillomavirus messenger RNA testing in physician- and self-collected specimens for cervical lesion detection in high-risk women, Kenya. Sex Transm Dis 40: 584-589.
37. Cuzick J, Cadman L, Mesher D, Austin J, Ashdown-Barr L, et al. (2013) Comparing the performance of six human papillomavirus tests in a screening population. Br J Cancer 108: 908-913.
38. Arbyn M, Roelens J, Cuschieri K, Cuzick J, Szarewski A, et al. (2013) The APTIMA HPV assay versus the Hybrid Capture 2 test in triage of women with ASC-US or LSIL cervical cytology: a meta-analysis of the diagnostic accuracy. Int J Cancer 132: 101-108.
39. Wright TC Jr, Schiffman M (2003) Adding a test for human papillomavirus DNA to cervical-cancer screening. N Engl J Med 348: 489-490.